• The QbD Group acquires regulatory affairs and pharmacovigilance company EUDRAC Ltd to expand its services for pharmaceutical customers

    Tuesday November 8th 2022

  • Bone Therapeutics to start a new Euronext equity story with a change of name to BioSenic, following the acquisition of a majority participation of Medsenic valued at EUR 40 million

    Tuesday October 25th 2022

  • Bone Therapeutics to regain worldwide rights to ALLOB

    Friday October 7th 2022

  • Pauwels Consulting takes over Science@Work

    Friday September 23rd 2022

  • Cellistic and Celyad Oncology announce GMP cell therapy manufacturing operations transaction

    Tuesday September 20th 2022

  • Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic

    Wednesday August 10th 2022

  • Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry

    Thursday June 23rd 2022

  • Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

    Wednesday June 22nd 2022

  • Your news here?

  • AGIO Capital and Business Solutions and AcademicLabs sign a strategic partnership agreement

    Wednesday June 15th 2022

  • Dolmen Engineering joins international consultancy company NIRAS

    Thursday June 9th 2022

  • GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.

    Tuesday May 31st 2022


Strategic Partners